| Literature DB >> 27940635 |
Helen Slater1, Joanne E Jordan2, Jason Chua1,3, Robert Schütze4, John D Wark5, Andrew M Briggs1,5,6.
Abstract
OBJECTIVE: To investigate young people's experiences of persistent musculoskeletal pain, including care needs and current service gaps as well as perceptions about the role of digital technologies to support their co-care.Entities:
Keywords: PAIN MANAGEMENT
Mesh:
Year: 2016 PMID: 27940635 PMCID: PMC5168607 DOI: 10.1136/bmjopen-2016-014007
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Psychometric measures used to characterise young people's musculoskeletal pain and psychological well-being
| Psychometric tool | Scoring |
|---|---|
| ÖMSPQ-SF: the SF (10 items) of the ÖMSPQ is appropriate for clinical and research purposes, as it demonstrates near equivalent accuracy, compared to the longer version, | Items are scored 0–10; 0 refers to the absence of impairment and 10 to severe impairment. Three items are reversed in order for all the questions to be oriented in the same direction. The total score will range between 1 and 100, with a score of >50 indicating higher estimated risk for future work disability. The SF has been tested in occupational and musculoskeletal adult cohorts in primary care. |
| CSQ (subscale 2; catastrophising). The catastrophising subscale of the CSQ | This subscale lists six items that are scored using a 7-point Likert scale with responses 0 indicating ‘never’ to 6 indicating ‘always'. Scores can range from 0 to 36 with higher scores indicating greater catastrophising beliefs. |
| HADS: HADS is a 14-item measure of self-reported symptoms of anxiety and depression widely validated and with good psychometric properties. | The anxiety and depression scales each have seven questions, and scores are categorised as normal (0–7), mild (8–10), moderate (11–14) and severe (15–21). |
| PSEQ: | There are 10 items, using a 7-point Likert scale (‘Not at all confident 0 to completely confident ‘6′), with all items summed for a total score with a possible range from 0 to 60 with a higher score indicating higher self-efficacy. |
| AQoL: AQoL is an 8-domain questionnaire (35 items) psychological super dimension subscales (ie, subscales 4–8 inclusive) was used to capture overall psychological well-being. | The psychological super dimension can be used as a stand-alone instrument, as it was derived to have independent content validity. By comparison with existing instruments, AQoL-8D has demonstrated advantages, including greater coverage of mental and social dimensions of health; similar results with respect to convergent and predictive validity and a higher correlation with subjective well-being. |
AQoL, Assessment of the Quality of Life; CSQ, Coping Skills Questionnaire; HADS, Hospital Anxiety and Depression Scale; OMSPQ-SF, Örebro Musculoskeletal Pain Screening Questionnaire-Short Form; PSEQ, Pain Self-Efficacy questionnaire.
Demographic characteristics of participants (n=23)
| Age (years) mean (SD) [minimum—maximum] | 20.8 (2.4) [17–24] |
| Gender (women) | 20 (87.0) |
| English as a first language | 22 (95.7) |
| Highest current level of education completed | |
| University | 8 (34.8) |
| TAFE* | 4 (17.4) |
| Year 12 (tertiary entrance)* | 8 (34.8) |
| Year 12 (other) | 3 (13.0) |
| Less than 3 year secondary | 0 |
| Currently at | |
| School | 3 (13.0) |
| University or TAFE | 14 (60.9) |
| Unemployed | 1 (4.4) |
| Employed (volunteer or paid work) | 5 (21.7) |
*n=2 participants indicated being at TAFE and undertaking tertiary examinations for year 12.
TAFE, technical and further education institutions.
Individual participant clinical characteristics (n=23)
| Code | Sex | Age | Diagnosis* | Pain duration (months) | Mental health conditions (yes/no) | Mental health duration (months) | ÖMSQ (possible score 1–100) | HADS (total: possible score 0–42) | PSEQ [possible score 0–60] | CSQ (catastrophising subscale; [possible score 0–36] | AQoL-8D; (MSD; possible score 0–100) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IP01 | F | 21 | JIA; fibromyalgia* | 90 | N | 43 | 8 | 43 | 13 | 69 | |
| IP02 | F | 23 | Fibromyalgia* | 84 | Y | 12 | 53 | 17 | 40 | 18 | 49 |
| IP03 | F | 24 | Neck/shoulders/back | 72 | Y | 48 | 45 | 15 | 46 | 3 | 61 |
| IP04 | F | 22 | Neck/back pain | 58 | Y | 37 | 57 | 25 | 43 | 9 | 29 |
| IP05 | F | 24 | Low back pain | 54 | N | 27 | 14 | 39 | 18 | 72 | |
| IP06 | F | 19 | Bilateral knee pain | 60 | N | 27 | 14 | 60 | 1 | 74 | |
| IP07 | F | 20 | Back pain/sciatica* | 38 | Y | 120 | 73 | 18 | 21 | 29 | 52 |
| IP08 | F | 24 | Shoulder/back* | 14 | Y | 34 | 40 | 22 | 52 | 6 | 54 |
| IP09 | M | 22 | AS*† | 84 | Y | 36 | 41 | 25 | 18 | 16 | 40 |
| IP010 | F | 20 | JIA* | 240 | Y | 12 | 60 | 14 | 46 | 6 | 60 |
| IP11 | F | 20 | CTD*‡ | 35 | Y | 60 | 49 | 26 | 38 | 5 | 33 |
| IP12 | F | 19 | Hips/knees/back | 60 | Y | 144 | 50 | 14 | 39 | 15 | 64 |
| IP13 | M | 21 | Back pain* | 32 | Y | 32 | 36 | 10 | 57 | 18 | 71 |
| IP14 | F | 24 | Fibromyalgia* | 37 | N | 42 | 10 | 46 | 18 | 74 | |
| IP15 | F | 24 | Ankylosing spondylitis/OP* | 54 | N | 33 | 9 | 37 | 6 | 70 | |
| IP16 | M | 22 | Low back pain/sciatica* | 56 | N | 33 | 5 | 60 | 8 | 87 | |
| IP17 | F | 23 | Inflammatory arthritis§/OA* | 126 | N | 31 | 4 | 56 | 4 | 79 | |
| IP18 | F | 19 | Fibromyalgia* | 87 | N | 52 | 10 | 45 | 18 | 59 | |
| FG01 | F | 18 | Knee pain* | 36 | N | 38 | 6 | 54 | 5 | 77 | |
| FG02 | F | 18 | Scoliosis (back)* | 90 | Y | 96 | 56 | 17 | 38 | 16 | 51 |
| FG03¶ | F | 17 | 38 | Y** | 20 | 2 | 57 | 6 | 71 | ||
| FG04¶ | F | 18 | Low back/hip pain*†† | 8 | Y | 6 | 47 | 17 | 10 | 26 | 48 |
| FG05¶ | F | 18 | 5 | Y | 39 | 45 | 27 | 54 | 11 | 56 |
Except where indicated otherwise, values are presented as n (percentages).
*Clinical diagnosis made by health professional.
†Also pituitary adenoma and acromegaly.
‡Unspecified Connective Tissue Disorder with Sjogren's features.
§Seronegative.
¶No specific clinical diagnosis was available from transcripts due to confidentiality requirements of the FG.
**Previously history of clinically diagnosed anxiety but now resolved.
††Comorbid endometriosis.
AQoL-8D, The Assessment of Quality of Life Eight Dimension Scale (psychological super dimension only); AS, ankylosing spondylitis; CSQ, Coping Strategies Questionnaire-Pain Factor 2: catastrophising subscale; CTD, connective tissue disorder; FG, focus group participant; HADS, Hospital Anxiety and Depression Scale; HADS-A, anxiety subscale; HADS-D, depression subscale; IP, individual participant; JIA, juvenile inflammatory arthritis; OA, osteoarthritis; ÖMSPQ-SF 10, Orebro Musculoskeletal Pain Screening Questionnaire-Short Form 10; OP, osteoporosis; PSEQ, Pain Self-Efficacy Questionnaire.
Topics identified by participants where more information was desired to assist young people with the management of their persistent pain
| Topic area | Specific information components |
|---|---|
| 1. Self-management |
Assist with managing information, actions and medication from all health professionals involved in care Pain management strategies Practical tips and strategies Tracking pain levels |
| 2. Online screening tools |
Screening/diagnostic tools |
| 3. Prevention |
Prevention of injury |
| 4. Education |
Education for health professionals Enhance patient health literacy Section for parents/carers Education for employers and employees Education for teachers and employers |
| 5. Pain physiology |
Insight into what causes pain and affects on the body |
| 6. Medication information |
Drug efficacy |
| 7. Support |
Online chat with peers Online chat/access to health professionals specialising in pain Motivational/inspirational spaces |
| 8. Available healthcare assistance |
Directory of health professionals specialising in pain management Online repository for best practice |